3-phenyl-5-(p-tolyl)-4,5-dihydro 1H-pyrazole-1-carbothioamide

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 3-phenyl-5-(p-tolyl)-4,5-dihydro 1H-pyrazole-1-carbothioamide
• 英文别名: 3-phenyl-5-p-tolyl-4,5-dihydro-1H-pyrazole-1-carbothioamide；3-(4-methylphenyl)-5-phenyl-3,4-dihydropyrazole-2-carbothioamide
• 化学式: C₁₇H₁₇N₃S
• 分子量: 295.408
• InChiKey: ZUKKWZVDWNDOIO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  21
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  73.7
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  溴乙酸 、 3-phenyl-5-(p-tolyl)-4,5-dihydro 1H-pyrazole-1-carbothioamide 在 sodium acetate 、 乙酸酐 、 溶剂黄146 作用下， 以75%的产率得到2-(3-phenyl-5-( p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)thiazol-4(5H)-one
  参考文献：
  名称：

  Design, synthesis and biological evaluation of pyrazolyl-thiazolinone derivatives as potential EGFR and HER-2 kinase inhibitors

  摘要：

  A series of pyrazolyl-thiazolinone derivatives (E1-E36) have been designed and synthesized and their biological activities were also evaluated as potential EGFR and HER-2 kinase inhibitors. Thirty-four of the 36 compounds were reported for the first time. Among them, compound 2-(5-(4-bromophenyl)-3-p-tolyl-4,5-dihydro-1H-pyrazol-1-yl)thiazol-4(5H)-one (E28) displayed the most potent inhibitory activity (IC50 = 0.24 mu M for EGFR and IC50 = 1.07 mu M for HER-2). Antiproliferative assay results indicated that compound E28 owned high antiproliferative activity against MCF-7, B16-F10 and HCT-116 in vitro, with IC50 value of 0.30, 0.54, and 0.70 mu M, respectively. Docking simulation was further performed to position compound E28 into the EGFR active site to determine the probable binding model. Based on the preliminary results, compound E28 with potent inhibitory activity in tumor growth would be a potential anticancer agent. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2012.01.051
• 作为产物：
  描述：

  对甲基苯甲醛 在 sodium hydroxide 作用下， 以 乙醇 、 水 为溶剂， 生成 3-phenyl-5-(p-tolyl)-4,5-dihydro 1H-pyrazole-1-carbothioamide
  参考文献：
  名称：

  一些基于硫代氨基甲酰基的新型抗组织蛋白酶药物。

  摘要：

  由于组织蛋白酶参与细胞外基质的降解和内源性蛋白质更新，它们已成为各种组织退行性疾病的重要靶标。据报道，在不同的患病部位，组织蛋白酶水平相对于内源性抑制剂浓度降低而升高。因此，特定潜在抗组织蛋白酶剂的设计和合成具有重要意义。开发的大多数潜在的抗组织蛋白酶药物都具有带有主动弹头的基于肽的结构。由于口服不稳定和与肽基抑制剂有关的免疫原性问题，近二十年来非肽组织蛋白酶抑制剂的合成和评估。本工作提供了一种详细的结构活性关系，用于开发基于以下方面的潜在非肽抗组织蛋白酶药物合成的硫代氨基甲酰基非肽抑制剂文库的体外抑制研究。

  DOI：

  10.1016/j.bioorg.2020.104174

文献信息

• Pyrazoline based MAO inhibitors: Synthesis, biological evaluation and SAR studies
  作者：Monika Jagrat、Jagannath Behera、Samiye Yabanoglu、Ayse Ercan、Gulberk Ucar、Barij Nayan Sinha、Vadivelan Sankaran、Arijit Basu、Venkatesan Jayaprakash

  DOI：10.1016/j.bmcl.2011.05.057

  日期：2011.7

  Twenty-two pyrazoline derivatives were synthesized and tested for their human MAO (hMAO) inhibitory activity. Twelve molecules with unsubstituted ring A and substituted ring C (5–16) were found to be potent inhibitors of hMAO-A isoform with SIMAO-A in the order 103 and 104. Ten molecules with unsubstituted ring A and without ring C (21–30), in which eight molecules (21, 23–26, and 28–30) were selective

  合成了22种吡唑啉衍生物，并测试了其对人MAO（hMAO）的抑制活性。未取代的环A和取代的环C（十二分子5 - 16）被发现与SI hMAO-A同种型的强效抑制剂，MAO-A的顺序10 3和10 4。十个分子与未取代的环A和无环C（21 - 30），其中8个分子（21，23 - 26，和28 - 30）是选择性的hMAO-A，一个用于hMAO-B（22），另一1个非选择性（27）。环C的存在增加了针对hMAO-A的效力以及SI。然而，它的缺乏降低了针对hMAO-A和hMAO-B的效力和SI。
• Synthesis of new 2-(5-substituted-3-phenyl-2-pyrazolinyl)-1,3-thiazolino[5,4-b]quinoxaline derivatives and evaluation of their antiamoebic activity
  作者：Asha Budakoti、Abdul Roouf Bhat、Amir Azam

  DOI：10.1016/j.ejmech.2008.02.002

  日期：2009.3

  linyl))methane-1-thione derivatives (1a–8a) and 2-(5-substituted-3-phenyl-2-pyrazolinyl)-1,3-thiazolino[5,4-b]quinoxaline derivatives (1b–8b) and evaluated for their in vitro antiamoebic activity against HM1:IMSS strain of E. histolytica. All the compounds were characterized by electronic, IR, 1H NMR and mass spectroscopic data. It was observed that the antiamoebic activity enhances on modifying the

  在努力开发有效的antiamoebic剂，我们已经合成的查耳酮（1 - 8），2-氨基-5-取代的- （3-苯基（2-吡唑啉基））甲烷-1-硫酮衍生物（1A - 8A）和2-（ 5-取代的-3-苯基-2-吡唑啉基）-1,3-噻唑啉代[5,4- b ]喹喔啉衍生物（1b – 8b）并评估了它们对溶血性大肠杆菌HM1：IMSS菌株的体外抗氧活性。所有化合物的特征在于电子，IR，11 H NMR和质谱数据。观察到，通过改变查耳酮对吡唑啉和进而对喹喔啉的结构，抗厌氧活性增强。在人肾上皮细胞系上进行MTT测定以检查化合物的细胞毒性，并将结果与​​甲硝唑进行比较。与甲硝唑相比，化合物6b具有更好的抗氧活性和更低的毒性。
• Synthesis and Selective Inhibitory Activity Against Human COX-1 of Novel 1-(4-Substituted-thiazol-2-yl)-3,5-di(hetero)aryl-pyrazoline Derivatives
  作者：Simone Carradori、Daniela Secci、Adriana Bolasco、Celeste De Monte、Matilde Yáñez

  DOI：10.1002/ardp.201200249

  日期：2012.12

  (compounds 5, 6, 13, 16, and 17) displayed promising selectivity against hCOX‐1 in the micromolar range and were shown to have a selectivity index similar or better than the reference drugs (indometacin, diclofenac). The introduction of a phenyl or a 4‐F‐phenyl ring on the C5 associated with a 4‐substituted phenyl or a heteroaryl group on the C3 of (4‐substituted‐thiazol‐2‐yl)pyrazoline derivatives improved

  3,5-二(杂)芳基-1-硫代氨基甲酰基-2-反应得到新型1-(4-乙基羧酸酯-噻唑-2-基)-3,5-二(杂)芳基-2-吡唑啉衍生物吡唑啉与α-溴-丙酮酸乙酯。合成的化合物通过光谱数据得到证实，并进行了分析，以评估它们在体外抑制人类环氧合酶 (hCOX) 两种异构体的能力。一些衍生物（化合物 5、6、13、16 和 17）在微摩尔范围内对 hCOX-1 显示出有希望的选择性，并且显示出与参考药物（吲哚美辛、双氯芬酸）相似或更好的选择性指数。在（4-取代-噻唑-2-基）吡唑啉衍生物的 C3 上与 4-取代苯基或杂芳基相连的 C5 上引入苯基或 4-F-苯环提高了对 hCOX-的活性1.
• The mechanism of the reaction of hydrazines with α,β-unsaturated carbonyl compounds to afford hydrazones and 2-pyrazolines (4,5-dihydro-1H-pyrazoles): Experimental and theoretical results
  作者：Antonio de la Hoz、Ibon Alkorta、José Elguero

  DOI：10.1016/j.tet.2021.132413

  日期：2021.9

  The reaction of hydrazines with α,β-unsaturated carbonyl compounds to afford 2-pyrazolines was studied using a dissymmetric chalcone (phenyl/p-tolyl) and three hydrazines, hydrazine itself, phenylhydrazine and thiosemicarbazide. Several products were identified, and some reaction paths established thanks to the evolution of 1H and 13C NMR spectra with time. Theoretical calculations on energies and

  使用不对称查耳酮（苯基/对甲苯基）和三种肼（肼本身、苯肼和氨基硫脲）研究了肼与 α,β-不饱和羰基化合物反应生成 2-吡唑啉。由于1 H 和13 C NMR 光谱随时间的演变，确定了几种产物，并建立了一些反应路径。能量和化学位移的理论计算对于确定某些产品的结构至关重要。对于重要的步骤，计算了过渡态，而 IRC 证明需要找到一些意想不到的中间体。
• Harvesting greenish blue luminescence in gold(<scp>i</scp>) complexes and their application as promising bioactive molecules and cellular bioimaging agents
  作者：Lis R. V. Favarin、G. B. Laranjeira、Cristiane F. A. Teixeira、Heveline Silva、A. C. Micheletti、Lucas Pizzuti、Amilcar Machulek Júnior、Anderson R. L. Caires、Victor M. Deflon、Rafaela B. P. Pesci、C. N. Lima Rocha、J. R. Correa、L. M. C. Pinto、Gleison Antônio Casagrande

  DOI：10.1039/d0nj01339k

  日期：——

  This work presents new gold materials as promising antitumoral and antibacterial agents and their potential use as luminescent probes for cellular bioimaging.

  这项工作介绍了新型金材料作为有前途的抗肿瘤和抗菌剂，并且它们有潜力作为细胞生物成像的发光探针。